FiercePharma

ORENCIA® (abatacept) Shows Comparable Efficacy to Humira® (adalimumab) in Year Two Data from Head-to-Head Study in Patients with Moderate to Severe Rheumatoid Arthritis

Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of year two data from AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naïve rheumatoid arthritis (RA) Subjects With ...
FiercePharma

New Data Show That Subcutaneous Injection of an Investigational Formulation of ORENCIA® (abatacept) Provided Similar

Safety and efficacy data on the investigational subcutaneous formulation of ORENCIA in adults with moderate to severe rheumatoid arthritis to be presented at the American College of Rheumatology ...
Medscape

FDA Approves Subcutaneous Abatacept for RA

August 2, 2011 — The US Food and Drug Administration (FDA) has approved a subcutaneous formulation of abatacept (Orencia, Bristol-Myers Squibb Co) for the treatment of adults with moderate-to-severe ...
Medscape

FDA Approvals: Orencia and Revlimid

Dec. 29, 2005 — The U.S. Food and Drug Administration (FDA) has approved abatacept injection for the treatment of moderately to severely active rheumatoid arthritis in adults who have had an ...
The Daily Illini

A prescription medicine reduces symptoms in adults with moderate to severe rheumatoid arthritis.

(NAPSI)ORENCIA (abatacept) is the first and only biologic for the treatment of adults with moderate to severe rheumatoid arthritis (RA) available in both self-injectable (under the skin) and ...
MedPage Today

Case Study: RA Patient Develops Rare Reaction Related to Biologic Treatment

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical ...
UPI

Rheumatoid arthritis drug abatacept may also prevent the disease

Philip Day loved playing soccer so much that the 35-year-old software engineer founded a website -- FootballMatcher.com -- to help people connect for pickup games. The fun went on pause when Day ...
MedPage Today

Another Study Backs Treatment for Preclinical Rheumatoid Arthritis

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Inflammatory ...
Monthly Prescribing Reference

RA Drug Available in New Autoinjector Device

R arthritis Bristol-Myers Squibb announced the launch of Orencia (abatacept) ClickJect Autoinjector, a new autoinjector for adults with moderate to severe rheumatoid arthritis. The Orencia ClickJect ...
Drug Store News

RA patients may benefit from weekly injection of Orencia, study finds

NEW YORK Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a biotech drug made by Bristol-Myers Squibb for the disease as they do from receiving it via IV on a ...
Healthline

Rheumatoid Arthritis Drug Abatacept Shown to Prevent Disease in Clinical Trial

Share on Pinterest A new clinical trial found that abatacept, a drug used to treat rheumatoid arthritis, may also help to prevent the disease. filadendron/Getty Images A study has found that the drug ...